Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
4Front Ventures Corp. (FFNTF)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
5060 North 40th Street 85018
Phoenix, AZ, US
Phoenix, AZ, US
CEO
Andrew Fisher Thut
Website
4frontventures.com
IPO
2018-03-14
CIK 1783875 ISIN CA35086B2075
Also trades on
Canadian Securities Exchange · FFNT.CN (CAD)
Other OTC · FFNTF (USD)
Other OTC · FFVWF (USD)
Description
4Front Ventures Corp. is an American company specializing in the management and operation of licensed cannabis facilities across various U.S. states where such activities are legally permitted. Its operations are bifurcated into two primary divisions: THC Cannabis and Cannabidiol (CBD) Wellness. The firm engages in the cultivation, manufacturing, distribution, and retail of both cannabis and CBD products. As of December 31, 2021, it oversaw six dispensaries, primarily under the MISSION brand, situated in Massachusetts, Illinois, and Michigan. In addition to its direct product offerings, 4Front Ventures extends its business to include the provision of equipment, supplies, and intellectual property to other cannabis producers, importing and reselling these materials, leasing real estate to cultivators, and furnishing consulting expertise. Founded in 2011, the company is headquartered in Phoenix, Arizona.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1
Beta
0.19
Float Shares
483.52M
Free Float %
38.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -80.00% | -80.00% | -80.00% | -95.00% | -99.99% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-2.71
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-9.5% Q3'24: -25.5% (vs Q3'23)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-98.3% Q3'24: +92.5% (vs Q3'23)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-30.9% Q3'24: -3.3% (vs Q3'23)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-21.2% Q3'24: -25.4% (vs Q3'23)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-13.3% Q3'24: -9.7% (vs Q3'23)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+2.6% Q3'24: +39.9% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-13.92× Q3'24: -17.53× (vs Q3'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.06M
est: 25.20M (-83.9%)
|
19.03M
est: 25.20M (-24.5%)
|
57.64M
est: 66.55M (-13.4%)
|
104.57M
est: 121.65M (-14.0%)
|
107.66M
est: 133.68M (-19.5%)
|
97.44M
est: 116.53M (-16.4%)
|
88.72M
est.
|
336.35M
est.
|
363.49M
363.49M – 363.49M
+8.1% YoY
|
| EBITDA |
-46.05M
est: -8.08M (-469.8%)
|
-168.30M
est: -8.08M (-1,982.2%)
|
-20.60M
est: -21.34M (+3.5%)
|
-7.24M
est: -39.02M (+81.4%)
|
-2.40M
est: -42.87M (+94.4%)
|
-15.08M
est: -37.37M (+59.7%)
|
-28.46M
est.
|
-107.88M
est.
|
-116.58M
-116.58M – -116.58M
-8.1% YoY
|
| EBIT |
-48.06M
est: -9.68M (-396.5%)
|
-176.48M
est: -9.68M (-1,723.5%)
|
-29.16M
est: -25.56M (-14.1%)
|
-13.87M
est: -46.72M (+70.3%)
|
-7.51M
est: -51.34M (+85.4%)
|
-20.64M
est: -44.75M (+53.9%)
|
-34.07M
est.
|
-129.18M
est.
|
-139.60M
-139.60M – -139.60M
-8.1% YoY
|
| Net Income |
-52.55M
est: -32.48M (-61.8%)
|
-180.91M
est: -32.48M (-456.9%)
|
-47.05M
est: -19.49M (-141.4%)
|
-38.31M
est: -9.75M (-293.1%)
|
-46.90M
est: -17.33M (-170.7%)
|
-91.65M
est: -48.73M (-88.1%)
|
-51.26M
est.
|
116.94M
est.
|
129.94M
129.94M – 129.94M
+11.1% YoY
|
| SGA |
4.03M
est: 23.49M (-82.8%)
|
39.94M
est: 23.49M (+70.0%)
|
48.97M
est: 62.04M (-21.1%)
|
58.40M
est: 113.41M (-48.5%)
|
54.25M
est: 124.62M (-56.5%)
|
63.41M
est: 108.63M (-41.6%)
|
82.71M
est.
|
313.55M
est.
|
338.86M
338.86M – 338.86M
+8.1% YoY
|
| EPS |
-0.08
est: -0.05 (-53.0%)
|
-0.43
est: -0.05 (-760.0%)
|
-0.09
est: -0.03 (-200.0%)
|
-0.06
est: -0.02 (-332.0%)
|
-0.07
est: -0.03 (-164.7%)
|
-0.14
est: -0.08 (-86.7%)
|
-0.08
est.
|
0.18
est.
|
0.20
0.20 – 0.20
+11.1% YoY
|
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-73.20M
OE per share TTM
-0.09
Owner's Yield
-800,933.12%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
181.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
16
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Leonid Gontmakher | 428.24M | 40.59% | 46.50M | 381.74M | 46.50M | 10.00 | IN | United States of America | 2024-06-20 | ↗ |
| 2 | Arkadi Gontmakher | 399.38M | 37.98% | 17.62M | 381.74M | 17.62M | 10.00 | IN | United States of America | 2024-06-20 | ↗ |
| 3 | Roman Tkachenko | 398.08M | 37.80% | 16.33M | 381.74M | 16.33M | 10.00 | IN | United States of America | 2024-06-20 | ↗ |
| 4 | LI Lending, LLC | 381.74M | 36.32% | — | 381.74M | — | 10.00 | OO | Delaware, United States of America | 2024-06-20 | ↗ |
| 5 | CHETAN GULATI | 68.12M | 9.67% | 516.7K | 67.60M | 516.7K | — | IN | States of America | 2023-10-31 | ↗ |
| 6 | Capital Green Management, LLC | 67.60M | 9.60% | — | 67.60M | — | — | IA | York, United States of America | 2023-10-31 | ↗ |
| 7 | JOHN KADEN | 67.60M | 9.60% | — | 67.60M | — | — | IN | UNITED STATES OF AMERICA | 2023-10-31 | ↗ |
| 8 | SEAN STIEFEL | 67.60M | 9.60% | — | 67.60M | — | — | IN | States of America | 2023-10-31 | ↗ |
| 9 | Class A Shares of the Issuer. Each Class B Share is convertible into 80 Class A Shares. | 55.03M | 12.00% | 55.03M | — | 55.03M | — | PN | Delaware | 2020-05-29 | ↗ |
| 10 | CAPITAL GREEN CO-INVEST FUND, LLC | 43.35M | 6.20% | — | 43.35M | — | — | OO | United States of America | 2023-10-31 | ↗ |
| 11 | NAVY CAPITAL GREEN CO-INVEST PARTNERS, LLC | 43.35M | 6.20% | — | 43.35M | — | — | OO | DELAWARE, UNITED STATES OF AMERICA | 2023-10-31 | ↗ |
| 12 | Vladislav Orlovskii | 29.45M | 3.22% | 29.45M | — | 29.45M | 10.00 | IN | United States of America | 2024-06-20 | ↗ |
| 13 | Capital Green Fund, LP | 24.21M | 3.66% | — | 24.21M | — | — | PN | United States of America | 2023-10-31 | ↗ |
| 14 | Capital Green Management Partners, LLC | 24.21M | 3.66% | — | 24.21M | — | — | OO | York, United States of America | 2023-10-31 | ↗ |
| 15 | Oleg Orlovskii | 14.52M | 1.59% | 14.52M | — | 14.52M | 10.00 | IN | United States of America | 2024-06-20 | ↗ |
| 16 | NAVY CAPITAL GREEN HOLDINGS, LLC | 41.7K | 0.01% | — | 41.7K | — | — | OO | DELAWARE, UNITED STATES OF AMERICA | 2023-10-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
10.41M
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+10,409,750
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-12 | Kronberg Michael | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-11 | KRANE KRISTOPHER | Director | A-Award | A | Class A Subordinate Voting Shares | 1,792,768 | 0.04 | 71.7K | 2,204,038 | D | ↗ |
| 2025-04-11 | DAILY DAVID RYAN | Director | A-Award | A | Class A Subordinate Voting Shares | 1,792,768 | 0.04 | 71.7K | 2,204,038 | D | ↗ |
| 2025-03-29 | TKACHENKO ROMAN | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-29 | GULATI CHETAN | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-29 | GONTMAKHER LEONID | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-10 | Kronberg Michael | Officer | A-Award | A | Option to purchase SVS | 150,000 | 0.03 | 4.5K | 150,000 | D | ↗ |
| 2025-01-03 | TKACHENKO ROMAN | Director | D-Return | D | Stock Option (right to buy) | 1,100,000 | 0.15 | 165.0K | 0 | D | ↗ |
| 2024-12-23 | GONTMAKHER LEONID | Director | A-Award | A | Stock Option (right to buy) | 3,700,000 | 0.02 | 74.0K | 4,100,000 | D | ↗ |
| 2024-12-20 | GULATI CHETAN | Director | A-Award | A | Stock Option (right to buy) | 1,550,000 | 0.02 | 31.0K | 1,950,000 | D | ↗ |
| 2024-12-20 | DAILY DAVID RYAN | Director | A-Award | A | Stock Option (right to buy) | 1,200,000 | 0.02 | 24.0K | 1,600,000 | D | ↗ |
| 2024-12-16 | THUT ANDREW | Officer | D-Return | D | Stock Option (right to buy) | 4,000,000 | 0.17 | 680.0K | 0 | D | ↗ |
| 2024-12-16 | KRANE KRISTOPHER | Director / Officer | D-Return | D | Stock Option (right to buy) | 600,000 | 0.02 | 10.2K | 0 | D | ↗ |
| 2024-12-16 | CHOWSCANO KARL | Other | D-Return | D | Stock Option (right to buy) | 5,000,000 | 0.17 | 850.0K | 0 | I | ↗ |
| 2024-10-23 | Kronberg Michael | Officer | — | — | Stock Option | 150,000 | 0.10 | 15.0K | 0 | D | ↗ |
| 2024-07-25 | TKACHENKO ROMAN | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.09 | 36.0K | 2,200,000 | — | ↗ |
| 2024-07-25 | KRANE KRISTOPHER | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.09 | 36.0K | 4,729,840 | — | ↗ |
| 2024-07-25 | GULATI CHETAN | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.09 | 36.0K | 1,950,000 | — | ↗ |
| 2024-07-25 | GONTMAKHER LEONID | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.09 | 36.0K | 4,100,000 | — | ↗ |
| 2024-07-25 | DAILY DAVID RYAN | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.09 | 36.0K | 1,600,000 | — | ↗ |
| 2024-07-03 | Hunt Robert E | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-02 | TKACHENKO ROMAN | Director | A-Award | A | Class A Subordinate Voting Shares | 342,725 | 0.00 | — | 14,534,655 | — | ↗ |
| 2024-05-02 | THUT ANDREW | Officer | A-Award | A | Class A Subordinate Voting Shares | 9,000,000 | 0.00 | — | 23,084,778 | — | ↗ |
| 2024-05-02 | Kampian Peter | Officer | A-Award | A | Class A Subordinate Voting Shares | 877,321 | 0.00 | — | 877,321 | — | ↗ |
| 2024-05-02 | KRANE KRISTOPHER | Director | A-Award | A | Class A Subordinate Voting Shares | 411,270 | 0.00 | — | 10,826,550 | — | ↗ |
| 2024-05-02 | GONTMAKHER LEONID | Director | A-Award | A | Class A Subordinate Voting Shares | 342,725 | 0.00 | — | 42,801,636 | — | ↗ |
| 2024-05-02 | DAILY DAVID RYAN | Director | A-Award | A | Class A Subordinate Voting Shares | 411,270 | 0.00 | — | 433,270 | — | ↗ |
| 2024-05-02 | CHOWSCANO KARL | Director | A-Award | A | Class A Subordinate Voting Shares | 3,333,333 | 0.00 | — | 31,271,401 | — | ↗ |
| 2024-01-29 | LI LENDING, LLC | 10% Owner | — | D | 2024 Warrant | 36,702,127 | 0.11 | 3.96M | 0 | — | ↗ |
| 2023-12-28 | Kampian Peter | Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 0.11 | 216.0K | 2,000,000 | — | ↗ |
| 2023-12-01 | Kampian Peter | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-19 | GULATI CHETAN | Director | J-Other | A | Convertible Promissory Notes | 46,086,956 | 0.23 | 10.60M | 48,194,267 | — | ↗ |
| 2023-09-07 | GONTMAKHER LEONID | Officer | P-Purchase | A | Class A Subordinate Voting Shares | 20,000 | 0.24 | 4.8K | 41,473,411 | — | ↗ |
| 2023-09-06 | GONTMAKHER LEONID | Officer | P-Purchase | A | Class A Subordinate Voting Shares | 75,000 | 0.23 | 16.9K | 41,453,411 | — | ↗ |
| 2023-09-01 | Frederick Nicole | Officer | A-Award | A | Stock Option (right to buy) | 1,000,000 | 0.16 | 160.0K | 1,000,000 | — | ↗ |
| 2023-08-29 | GONTMAKHER LEONID | Officer | P-Purchase | A | Class A Subordinate Voting Shares | 14,500 | 0.13 | 1.8K | 32,078,161 | — | ↗ |
| 2023-08-17 | GONTMAKHER LEONID | Officer | A-Award | A | Class A Subordinate Voting Shares | 9,300,250 | 0.00 | — | 41,378,411 | — | ↗ |
| 2023-08-10 | LI LENDING, LLC | 10% Owner | — | D | 2023 Warrant | 100,358,824 | 0.17 | 17.06M | 0 | — | ↗ |
| 2023-08-04 | THUT ANDREW | Officer | A-Award | A | Class A Subordinate Voting Shares | 2,405,818 | 0.00 | — | 14,084,778 | — | ↗ |
| 2023-08-04 | CHOWSCANO KARL | — | A-Award | A | Class A Subordinate Voting Shares | 2,806,788 | 0.00 | — | 17,924,148 | — | ↗ |
| 2023-07-24 | Frederick Nicole | Officer | — | D | Stock Options (Right to Buy) | 30,000 | 0.13 | 3.9K | 0 | — | ↗ |
| 2023-07-24 | Adams Keith Edward | — | A-Award | A | Stock Option (right to buy) | 1,000,000 | 0.18 | 180.0K | 2,000,000 | — | ↗ |
| 2023-07-19 | Frederick Nicole | Officer | — | D | Stock Options (Right to Buy) | 75,000 | 0.16 | 12.0K | 0 | — | ↗ |
| 2023-06-30 | TKACHENKO ROMAN | Director | A-Award | A | Stock Option (right to buy) | 1,100,000 | 0.15 | 165.0K | 1,800,000 | — | ↗ |
| 2023-06-30 | Hunt Robert E | Director | A-Award | A | Stock Option (right to buy) | 1,050,000 | 0.15 | 157.5K | 1,050,000 | — | ↗ |
| 2023-06-23 | THUT ANDREW | Officer | D-Return | D | Stock Option (right to buy) | 500,000 | 0.65 | 325.0K | 5,965,040 | — | ↗ |
| 2023-06-23 | KRANE KRISTOPHER | Director | D-Return | D | Stock Option (right to buy) | 250,000 | 0.65 | 162.5K | 3,329,840 | — | ↗ |
| 2023-06-23 | GULATI CHETAN | Director | D-Return | D | Stock Option (right to buy) | 350,000 | 0.53 | 185.5K | 0 | — | ↗ |
| 2023-06-23 | GONTMAKHER LEONID | Officer | D-Return | D | Stock Option (right to buy) | 3,000,000 | 0.58 | 1.74M | 0 | — | ↗ |
| 2023-06-23 | DAILY DAVID RYAN | Director | A-Award | A | Stock Option (right to buy) | 1,200,000 | 0.14 | 168.0K | 1,200,000 | — | ↗ |
| 2023-06-23 | CHOWSCANO KARL | — | D-Return | D | Stock Option (right to buy) | 1,803,200 | 0.46 | 829.5K | 5,000,000 | — | ↗ |
| 2023-05-29 | Adams Keith Edward | Officer | A-Award | A | Stock Option (right to buy) | 1,000,000 | 0.16 | 160.0K | 2,000,000 | — | ↗ |
| 2023-05-26 | TKACHENKO ROMAN | Director | D-Return | D | Stock Option (right to buy) | 600,000 | 0.80 | 480.0K | 700,000 | — | ↗ |
| 2023-05-26 | Hunt Robert E | Director | D-Return | A | Stock Option (right to buy) | 450,000 | 0.53 | 238.5K | 0 | — | ↗ |
| 2023-04-28 | KRANE KRISTOPHER | Director | A-Award | A | Stock Option (right to buy) | 600,000 | 0.17 | 102.0K | 14,745,120 | — | ↗ |
| 2023-04-28 | Frederick Nicole | Officer | — | D | Stock Options (Right to Buy) | 100,000 | 0.17 | 17.0K | 0 | — | ↗ |
| 2023-04-21 | CHOWSCANO KARL | — | A-Award | A | Stock Option (right to buy) | 5,000,000 | 0.17 | 850.0K | 10,303,200 | — | ↗ |
| 2023-04-18 | THUT ANDREW | Officer | A-Award | A | Stock Option (right to buy) | 4,000,000 | 0.17 | 680.0K | 14,011,040 | — | ↗ |
| 2022-12-05 | TKACHENKO ROMAN | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.00 | — | 1,900,000 | — | ↗ |
| 2022-12-05 | Patel Amit Ramanlal | Director | A-Award | A | Stock Option (right to buy) | 200,000 | 0.00 | — | 800,000 | — | ↗ |
| 2022-12-05 | Hunt Robert E | Director | A-Award | D | Stock Option (right to buy) | 450,000 | 0.00 | — | 1,050,000 | — | ↗ |
| 2022-12-05 | GULATI CHETAN | Director | A-Award | A | Stock Option (right to buy) | 350,000 | 0.00 | — | 1,750,000 | — | ↗ |
| 2022-12-05 | DAILY DAVID RYAN | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 0.00 | — | 1,200,000 | — | ↗ |
| 2022-12-05 | CHOWSCANO KARL | Director | A-Award | A | Stock Option (right to buy) | 5,000,000 | 0.00 | — | 10,303,200 | — | ↗ |
| 2022-11-22 | THUT ANDREW | Officer | A-Award | A | Stock Option (right to buy) | 4,000,000 | 0.00 | — | 14,011,040 | — | ↗ |
| 2022-11-22 | Adams Keith Edward | Officer | A-Award | A | Stock Option (right to buy) | 1,000,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2022-11-16 | THUT ANDREW | Officer | A-Award | A | Stock Option (right to buy) | 5,045,600 | 0.00 | — | 10,011,040 | — | ↗ |
| 2022-11-16 | GONTMAKHER LEONID | Officer | A-Award | A | Class A Subordinate Voting Shares | 1,750,604 | 0.00 | — | 32,063,661 | — | ↗ |
| 2022-11-16 | CHOWSCANO KARL | Director | A-Award | A | Stock Option (right to buy) | 1,803,200 | 0.00 | — | 5,303,200 | — | ↗ |
| 2022-08-03 | LENTZSCH KATHI P | Director | A-Award | A | Stock Option (right to buy) | 250,000 | 0.00 | — | 1,100,000 | — | ↗ |
| 2022-06-29 | GULATI CHETAN | Director | J-Other | D | Class A Subordinate Voting Shares | 2,068,082 | 0.00 | — | 21,734,345 | — | ↗ |
| 2022-06-17 | GULATI CHETAN | Director | S-Sale | D | Class A Subordinate Voting Shares | 7,500 | 0.63 | 4.7K | 23,802,427 | — | ↗ |
| 2022-06-17 | Adams Keith Edward | Officer | S-Sale | A | Stock Option (right to buy) | 1,000,000 | 0.00 | — | 1,000,000 | — | ↗ |
| 2022-06-15 | GULATI CHETAN | Director | S-Sale | D | Class A Subordinate Voting Shares | 500 | 0.66 | 330.00 | 23,809,927 | — | ↗ |
| 2022-06-13 | GULATI CHETAN | Director | S-Sale | D | Class A Subordinate Voting Shares | 168,000 | 0.67 | 112.6K | 23,811,427 | — | ↗ |
| 2022-06-09 | GULATI CHETAN | Director | S-Sale | D | Class A Subordinate Voting Shares | 300,000 | 0.68 | 204.0K | 23,979,427 | — | ↗ |
| 2022-06-09 | Adams Keith Edward | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-06 | GULATI CHETAN | Director | S-Sale | D | Class A Subordinate Voting Shares | 47,000 | 0.72 | 33.8K | 27,174,742 | — | ↗ |
| 2022-04-27 | Hunt Robert E | Director | A-Award | A | Stock Option (right to buy) | 600,000 | 0.68 | 408.0K | 600,000 | — | ↗ |
| 2022-04-13 | GULATI CHETAN | Director | J-Other | A | Class A Subordinate Voting Shares | 41,696 | 4,192,562.00 | 174.81B | 27,221,742 | — | ↗ |
| 2022-04-12 | Patel Amit Ramanlal | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-12 | Hunt Robert E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-06 | GULATI CHETAN | Director | P-Purchase | A | 6% Unsecured Convertible Note | 9,028,000 | 1.03 | 9.30M | 9,028,000 | — | ↗ |
| 2021-06-23 | LENTZSCH KATHI P | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 1.27 | 63.5K | 850,000 | — | ↗ |
| 2021-04-13 | GULATI CHETAN | Director | C-Conversion | D | 3% Unsecured Convertible Note | 300,000 | 0.46 | 138.0K | 0 | — | ↗ |
| 2021-03-18 | THUT ANDREW | Officer | A-Award | A | Employee Stock Option (right to buy) | 2,000,000 | 1.13 | 2.26M | 5,120,396 | — | ↗ |
| 2021-03-18 | GULATI CHETAN | Director | A-Award | A | Stock Option | 200,000 | 1.30 | 260.0K | 200,000 | — | ↗ |
| 2021-03-18 | FELTHAM JOSEPH R | Officer | A-Award | A | Employee Stock Option (right to buy) | 750,000 | 1.13 | 847.5K | 750,000 | — | ↗ |
| 2021-01-13 | GULATI CHETAN | Director | C-Conversion | A | Class A Subordinate Voting Shares | 4,403,272 | 0.25 | 1.10M | 7,223,272 | — | ↗ |
| 2021-01-01 | TKACHENKO ROMAN | Director | — | — | Class A Subordinate Voting Shares | 0 | 0.00 | — | 14,191,930 | D | ↗ |
| 2021-01-01 | THUT ANDREW | Officer | — | D | Class C Multiple Voting Shares | 154,956 | 0.00 | — | 0 | — | ↗ |
| 2021-01-01 | Rey Eric J. | Director | — | D | Stock Option | 200,000 | 0.87 | 174.0K | 0 | — | ↗ |
| 2021-01-01 | ROSEN JOSHUA NATHANIEL | Director | — | D | Stock Option | 2,000,000 | 0.79 | 1.58M | 0 | — | ↗ |
| 2021-01-01 | LENTZSCH KATHI P | Director | — | D | Stock Option | 600,000 | 0.63 | 378.0K | 0 | — | ↗ |
| 2021-01-01 | KRANE KRISTOPHER | Officer | — | D | Class A Subordinate Voting Shares | 0 | 0.00 | — | 10,415,280 | — | ↗ |
| 2021-01-01 | GULATI CHETAN | Director | — | — | Class A Subordinate Voting Shares | 0 | 0.00 | — | 7,077,335 | I | ↗ |
| 2021-01-01 | GONTMAKHER LEONID | Director / Officer | — | D | Stock Option | 700,000 | 0.79 | 553.0K | 0 | — | ↗ |
| 2021-01-01 | FELTHAM JOSEPH R | Officer | — | D | Stock Option | 750,000 | 0.63 | 472.5K | 0 | — | ↗ |
| 2021-01-01 | Dorsey Nicolle | Officer | — | D | Stock Option | 500,000 | 0.63 | 315.0K | 0 | — | ↗ |
| 2021-01-01 | DAILY DAVID RYAN | Director | — | D | Class A Subordinate Voting Shares | 0 | 0.00 | — | 22,000 | — | ↗ |
| 2021-01-01 | CHOWSCANO KARL | — | — | I | Class A Subordinate Voting Shares | 0 | 0.00 | — | 15,117,360 | — | ↗ |
| 2020-11-20 | GULATI CHETAN | Director | — | — | Warrants | 1,410,000 | 0.71 | 1.00M | 0 | I | ↗ |
| 2020-07-07 | GULATI CHETAN | Director | — | — | 3% Unsecured Convertible Note | 300,000 | 0.46 | 138.0K | 0 | I | ↗ |
| 2020-05-14 | GULATI CHETAN | Director | — | — | 5% Subordinated Secured Convertible Note | 4,395,582 | 0.25 | 1.10M | 0 | I | ↗ |
| 2019-07-31 | THUT ANDREW | Officer | — | D | Stock Option | 1,965,440 | 0.08 | 157.2K | 0 | — | ↗ |
| 2019-07-31 | ROSEN JOSHUA NATHANIEL | Director | — | D | Stock Option | 327,600 | 0.08 | 26.2K | 0 | — | ↗ |
| 2019-07-31 | KRANE KRISTOPHER | Officer | — | D | Stock Option | 2,729,840 | 0.08 | 218.4K | 0 | — | ↗ |
| 2019-07-31 | FELTHAM JOSEPH R | Officer | — | D | Stock Option | 109,200 | 0.08 | 8.7K | 0 | — | ↗ |
| 2018-12-11 | TKACHENKO ROMAN | Director | — | D | Stock Option | 700,000 | 0.79 | 553.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-55.2K
Shares Outstanding
1.25B
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Leonid Gontmakher Chief Executive Officer and Director Keith Adams Chief Financial Officer Andrew Thut Chief Investment Officer & Interim Chief Financial Officer Joseph Feltham Chief Operating Officer Peter Kampian | 171.8K | 204.7K | 206.3K | 101.7K | — | — | 684.4K | 45.00% | ↗ |
| 2 | 2022 | Andrew Thut Chief Investment Officer and former Interim Chief Financial Officer | 340.5K | — | — | 1.17M | — | — | 1.51M | 77.52% | ↗ |
| 3 | 2022 | Leonid Gontmakher Chief Executive Officer | 400.0K | — | — | 400.0K | — | — | 800.0K | 50.00% | ↗ |
| 4 | 2022 | Joseph Feltham Former Chief Operating Officer | 300.0K | — | — | 167.1K | — | — | 467.1K | 35.78% | ↗ |
| 5 | 2022 | Leonid Gontmakher Chief Executive Officer and Director Keith Adams Chief Financial Officer Andrew Thut Chief Investment Officer & Interim Chief Financial Officer Joseph Feltham Chief Operating Officer Peter Kampian | 174.9K | — | — | 253.5K | — | — | 428.5K | 59.18% | ↗ |
| 6 | 2022 | Keith Adams Chief Financial Officer | 174.9K | — | — | 253.5K | — | — | 428.5K | 59.18% | ↗ |
| 7 | 2021 | Joshua Rosen Chief Executive Officer and Director | 400.0K | — | — | — | — | — | 400.0K | 0.00% | ↗ |
| 8 | 2021 | Leonid Gontmakher Chief Executive Officer | 400.0K | — | — | — | — | — | 400.0K | 0.00% | ↗ |
| 9 | 2021 | Andrew Thut Chief Investment Officer and former Interim Chief Financial Officer | 300.0K | — | — | — | — | — | 300.0K | 0.00% | ↗ |
| 10 | 2021 | Joseph Feltham Chief Operating Officer | 300.0K | — | — | — | — | — | 300.0K | 0.00% | ↗ |
| 11 | 2021 | Joseph Feltham Former Chief Operating Officer | 250.0K | — | — | — | — | — | 250.0K | 0.00% | ↗ |
| 12 | 2021 | Nicolle Dorsey Chief Financial Officer | 73.8K | — | — | — | — | — | 73.8K | 0.00% | ↗ |
| 13 | 2020 | Leonid Gontmakher Chief Executive Officer and Director | 400.0K | 450.0K | — | 437.4K | — | — | 1.29M | 33.98% | ↗ |
| 14 | 2020 | Joseph Feltham Chief Operating Officer | 205.9K | 100.0K | — | 474.6K | — | — | 780.5K | 60.81% | ↗ |
| 15 | 2020 | Joshua Rosen Chief Executive Officer and Director | 348.3K | 200.0K | — | 114.1K | — | — | 662.5K | 17.23% | ↗ |
| 16 | 2020 | Andrew Thut, Chief Investment Officer | 223.0K | 250.0K | — | 151.2K | — | — | 624.1K | 24.22% | ↗ |
| 17 | 2020 | Andrew Thut Interim Chief Financial Officer and Chief Investment Officer | 223.0K | 250.0K | — | 151.2K | — | — | 624.1K | 24.22% | ↗ |
| 18 | 2020 | Brad Kotansky Chief Financial Officer | 201.7K | — | — | 142.3K | — | — | 344.0K | 41.35% | ↗ |
| 19 | 2020 | Nicolle Dorsey Chief Financial Officer | 203.0K | — | — | 116.9K | — | — | 319.8K | 36.54% | ↗ |
| 20 | 2019 | Joseph Feltham Chief Operating Officer | 160.8K | — | — | 464.5K | — | — | 625.3K | 74.29% | ↗ |
| 21 | 2019 | Joshua Rosen Chief Executive Officer and Director | 371.6K | 46.6K | — | — | — | — | 418.2K | 0.00% | ↗ |
| 22 | 2019 | Andrew Thut, Chief Investment Officer | 212.6K | 20.3K | — | 83.2K | — | — | 316.0K | 26.32% | ↗ |
| 23 | 2019 | Andrew Thut Interim Chief Financial Officer and Chief Investment Officer | 212.6K | 20.3K | — | 83.2K | — | — | 316.0K | 26.32% | ↗ |
| 24 | 2019 | Brad Kotansky Chief Financial Officer | 115.4K | — | — | 175.7K | — | — | 291.1K | 60.37% | ↗ |
| 25 | 2019 | Leonid Gontmakher Chief Executive Officer and Director | 166.7K | — | — | 116.4K | — | — | 283.1K | 41.13% | ↗ |
| 26 | 2019 | Nicolle Dorsey Chief Financial Officer | 68.5K | — | — | 87.9K | — | — | 156.3K | 56.21% | ↗ |
| 27 | 2019 | Dave Croom Chief Financial Officer | 14.6K | — | — | 45.2K | — | — | 59.7K | 75.59% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrew Fisher Thut | Chief Executive Officer & Corporate Secretary | 648.2K | male |
| Kristopher Tutundjian Krane | Co-Founder & Strategic Advisor | 51.8K | male |
| Christopher Wimmer | General Counsel | — | male |
| Karl Chowscano | Consulting President | — | male |
| Matthew Stevens | Vice President of Operations - Illinois & Head of Cultivation | — | male |
| Michael Kronberg | Director of Finance | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FFNTF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
